On August 29, 2023, the World Health Organization's (WHO) C-TAP (COVID-19 Technology Access Pool) and the United Nations' Medicines Patent Pool (MPP) jointly announced that Medigen Vaccine Biologics Corporation license the COVID-19 vaccine technology to MPP/C-TAP. In the future, if further licenses are granted to third parties, MVC can charge reasonable and affordable royalty fees to facilitate the widespread global application of vaccine manufacturing technology. Date of occurrence of the event: August 29, 2023.